CIK: 1763494 - Address: C/o Travere Therapeutics, Inc., 3611 Valley Centre Dr., Suite 300, San Diego, CA 92130
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/2/24 16:06
2/1/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS.d-1668.700-19-5351D
1/25/24 16:10
1/23/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS-718.960-8-3235D
9/5/23 20:10
9/5/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS-6614.710-4-2243D
2/2/23 18:58
2/1/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS.d-18222.250-8-3237D
1/26/23 16:05
1/24/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS-13921.500-6-4148D
1/6/23 16:05
1/5/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS-11720.750-6-4154D
2/11/22 16:05
2/10/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS-13527.840-5-3160D
2/2/22 16:16
1/31/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS.d-13227.400-5-3165D
1/26/22 16:33
1/24/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS-19724.980-8-6132D
1/6/22 16:03
1/4/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsDube Eric MCADOCEOS.m-52130.080-17-11140D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact